Ryan Baum

Ryan Baum is an experienced healthcare investor currently serving as an Investor at Bridger Capital LLC since September 2017. Prior to this role, Ryan worked as an Investment Analyst at SSR LLC from January 2011 to August 2017, focusing on healthcare investment research. Earlier in the career, Ryan was a Consultant at IMS Consulting Group, where responsibilities included biopharma management consulting from March 2008 to December 2010. Ryan Baum holds a degree from Duke University.